Skip to main content

Table 3 Prevalence of infection and distribution of HCV genotypes among people who used illicit drugs

From: Hepatitis C virus infection status and associated factors among a multi-site sample of people who used illicit drugs in the Amazon region

Marker Prevalence 95% CI
Positive/Total %
HCV infection
 All (EIA+) 577/1666 34.6 28.3–41.1
 Active (EIA+ and PCR+) 384/1666 23.0 17.9–28.9
 Non-active (EIA+ Immuno Blot+ and PCR -) 193/1666 11.6 5.5–18.4
Genotypes
 Genotype 1 308/384 80.2 75.7–85.2
 Genotype 3 72/384 18.8 12.7–25.0
 Genotype 1 + Genotype 3 4/384 1.0 0.0–4.6